research

By design: targeting PARP trials is better for patients

Does screening really not save lives?

New $15m centre to develop next-gen drugs

No English? No trial: Why CALD patients are left out of cancer research

Clinical trials report card reveals winners and losers

Eureka prizes run and won

Smyth melanoma research controversy catches Peter Mac in its web

SMS plan to improve bowel screening participation
